{"hands_on_practices": [{"introduction": "Understanding the quantitative impact of a competitive inhibitor is a cornerstone of enzyme kinetics. This first exercise provides a direct application of the fundamental equation for competitive inhibition, allowing you to calculate how the presence of an inhibitor alters the enzyme's apparent affinity for its substrate. Mastering this calculation is the first step toward predicting an inhibitor's efficacy in a biological system [@problem_id:2071823].", "problem": "A biochemist is investigating a new potential therapeutic agent designed to target a specific metabolic enzyme. The enzyme is known to have a Michaelis constant ($K_M$) of 5 µM for its substrate. The therapeutic agent is identified as a competitive inhibitor of this enzyme. In a series of kinetic experiments, the inhibitor is determined to have an inhibition constant ($K_I$) of 2 nM. For a subsequent assay, the biochemist prepares a reaction mixture containing a concentration of this inhibitor equal to 10 nM. Calculate the apparent Michaelis constant ($K_{M,app}$) for the enzyme under these assay conditions.\n\nExpress your answer in units of micromolar (µM).", "solution": "For competitive inhibition in Michaelis–Menten kinetics, the effect of inhibitor concentration $[I]$ with inhibition constant $K_I$ is to scale the Michaelis constant by the factor\n$$\n\\alpha = 1 + \\frac{[I]}{K_I}.\n$$\nThe apparent Michaelis constant is therefore\n$$\nK_{M,app} = \\alpha K_M = \\left(1 + \\frac{[I]}{K_I}\\right) K_M.\n$$\nTo evaluate $\\alpha$, $[I]$ and $K_I$ must be expressed in the same concentration units. Given $[I] = 10$ nanomolar and $K_I = 2$ nanomolar, their ratio is\n$$\n\\frac{[I]}{K_I} = \\frac{10}{2} = 5,\n$$\nso\n$$\n\\alpha = 1 + 5 = 6.\n$$\nWith $K_M = 5$ micromolar, the apparent Michaelis constant is\n$$\nK_{M,app} = 6 \\times 5 = 30\n$$\nin micromolar units.", "answer": "$$\\boxed{30}$$", "id": "2071823"}, {"introduction": "Biochemical research often involves working backward from experimental observations to deduce underlying molecular properties. This problem challenges you to interpret a specific kinetic outcome—the doubling of the apparent $K_M$—to determine the inhibitor's binding affinity, its $K_I$ value. This practice sharpens your ability to connect kinetic data to the fundamental constants that govern enzyme-inhibitor interactions [@problem_id:2071801].", "problem": "A team of biochemists is developing a new drug to act as a competitive inhibitor for a specific human enzyme involved in a metabolic disease. The enzyme's catalytic activity follows Michaelis-Menten kinetics. The team first characterizes the enzyme in the absence of any inhibitor and determines its Michaelis constant, $K_M$, for its primary substrate.\n\nIn the next phase of the study, they introduce the new drug candidate at a fixed concentration of $[I] = 6.25 \\times 10^{-5}$ M. In the presence of this inhibitor, they observe that the substrate concentration required to achieve one-half of the maximal reaction velocity, $V_{max}$, is now exactly double the original $K_M$ value measured without the inhibitor.\n\nUsing this experimental finding, calculate the inhibition constant, $K_I$, which quantifies the inhibitor's binding affinity for the enzyme. Express your answer in units of micromolar (µM) and round to three significant figures.", "solution": "Michaelis–Menten kinetics without inhibitor is given by\n$$\nv=\\frac{V_{\\max}[S]}{K_{M}+[S]}.\n$$\nIn the presence of a competitive inhibitor at concentration $[I]$, the apparent Michaelis constant increases to\n$$\nK_{M,app}=K_{M}\\left(1+\\frac{[I]}{K_{I}}\\right),\n$$\nwhile $V_{\\max}$ is unchanged.\n\nAt half-maximal velocity, $v=\\frac{V_{\\max}}{2}$, solving\n$$\n\\frac{V_{\\max}[S]}{K_{M,app}+[S]}=\\frac{V_{\\max}}{2}\n$$\ngives $[S]=K_{M,app}$. The experiment reports that the substrate concentration required for half of $V_{\\max}$ is exactly double the original $K_M$, so\n$$\nK_{M,app}=2K_{M}.\n$$\nEquating the two expressions for $K_{M,app}$,\n$$\nK_{M}\\left(1+\\frac{[I]}{K_{I}}\\right)=2K_{M}\n\\;\\;\\Rightarrow\\;\\;\n1+\\frac{[I]}{K_{I}}=2\n\\;\\;\\Rightarrow\\;\\;\n\\frac{[I]}{K_{I}}=1\n\\;\\;\\Rightarrow\\;\\;\nK_{I}=[I].\n$$\nWith $[I]=6.25\\times 10^{-5}\\,\\mathrm{M}$ and using $1\\,\\mathrm{M}=10^{6}\\,\\mathrm{\\mu M}$,\n$$\nK_{I}=6.25\\times 10^{-5}\\times 10^{6}\\,\\mathrm{\\mu M}\n=6.25\\times 10^{1}\\,\\mathrm{\\mu M}\n=62.5\\,\\mathrm{\\mu M}.\n$$\nRounded to three significant figures (already satisfied), the inhibition constant in micromolar is $62.5$.", "answer": "$$\\boxed{62.5}$$", "id": "2071801"}, {"introduction": "This final practice simulates a realistic drug discovery scenario, moving beyond simple calculations to the analysis of raw experimental data. You will be tasked with determining an inhibitor's $K_I$ from a dataset of initial reaction velocities measured under various conditions. This comprehensive exercise integrates multiple concepts, requiring you to first determine the enzyme's intrinsic kinetic parameters ($V_{max}$ and $K_M$) before characterizing the inhibitor, mirroring the workflow of a research biochemist [@problem_id:2071808].", "problem": "A clinically relevant mutant of the enzyme Phosphofructokinase-2 (PFK-2), designated PFK-2-M, is known to be overactive and contributes to unregulated metabolic pathways in a specific cell line. A novel synthetic compound, PX-784, is being evaluated as a potential therapeutic agent by characterizing its effect on the enzyme's kinetics.\n\nA series of kinetic experiments were performed. In each experiment, the initial reaction velocity, $v_0$, was measured at various concentrations of the inhibitor PX-784, while the concentration of the substrate, fructose-6-phosphate ([S]), was held at a fixed value. This procedure was carried out for two different fixed concentrations of the substrate. The collected data is presented below. All concentrations are given in micromolar ($\\mu$M), and the velocities are in nanomoles per second ($\\text{nmol s}^{-1}$).\n\nData for substrate concentration $[S] = 25.0$ $\\mu$M:\n| [PX-784] ($\\mu$M) | $v_0$ ($\\text{nmol s}^{-1}$) |\n|:-----------------:|:--------------------------:|\n| 0.0 | 33.3 |\n| 10.0 | 25.0 |\n| 20.0 | 20.0 |\n| 40.0 | 14.3 |\n| 60.0 | 11.1 |\n\nData for substrate concentration $[S] = 100.0$ $\\mu$M:\n| [PX-784] ($\\mu$M) | $v_0$ ($\\text{nmol s}^{-1}$) |\n|:-----------------:|:--------------------------:|\n| 0.0 | 66.7 |\n| 10.0 | 57.1 |\n| 20.0 | 50.0 |\n| 40.0 | 40.0 |\n| 60.0 | 33.3 |\n\nAssuming the data perfectly fits a standard model of reversible enzyme inhibition, calculate the inhibitor constant, $K_I$, for the compound PX-784. Express your answer in units of micromolar ($\\mu$M) and round to three significant figures.", "solution": "We assume reversible inhibition following Michaelis–Menten kinetics. For competitive inhibition, the initial velocity at fixed substrate concentration $S$ and inhibitor concentration $I$ is\n$$\nv \\;=\\; \\frac{V_{\\max}\\, S}{K_M\\!\\left(1+\\frac{I}{K_I}\\right)+S}\\,,\n$$\nwhich reduces at $I=0$ to the Michaelis–Menten form\n$$\nv \\;=\\; \\frac{V_{\\max}\\, S}{K_M+S}\\,.\n$$\nInspection of the data shows that at a given $I$, inhibition is weaker at the higher $S$ (for example, at $I=10$, $v$ changes from $33.3$ to $25.0$ at $S=25$, a larger fractional drop than from $66.7$ to $57.1$ at $S=100$), which is consistent with competitive inhibition and inconsistent with pure noncompetitive (which would give the same fractional inhibition at both $S$) or uncompetitive (which typically shows stronger inhibition at higher $S$). We therefore proceed with the competitive model.\n\nFirst determine $V_{\\max}$ and $K_M$ from the $I=0$ data. Let $(S_{1},v_{1})=(25.0,33.3)$ and $(S_{2},v_{2})=(100.0,66.7)$ (concentrations in micromolar, velocities in nanomoles per second). Then\n$$\nv_{1} \\;=\\; \\frac{V_{\\max} S_{1}}{K_M+S_{1}}, \n\\qquad\nv_{2} \\;=\\; \\frac{V_{\\max} S_{2}}{K_M+S_{2}}.\n$$\nTaking the ratio,\n$$\n\\frac{v_{2}}{v_{1}} \\;=\\; \\frac{S_{2}}{K_M+S_{2}} \\cdot \\frac{K_M+S_{1}}{S_{1}}.\n$$\nWith $S_{2}=4 S_{1}$ and $v_{2}\\approx 2 v_{1}$ (from the data), this gives\n$$\n2 \\;=\\; \\frac{4 S_{1}}{K_M+4S_{1}} \\cdot \\frac{K_M+S_{1}}{S_{1}}\n\\;\\;\\Longrightarrow\\;\\;\n2\\left(K_M+4S_{1}\\right) \\;=\\; 4\\left(K_M+S_{1}\\right)\n\\;\\;\\Longrightarrow\\;\\;\nK_M \\;=\\; 2 S_{1}.\n$$\nWith $S_{1}=25.0$, this yields $K_M=50.0$. Then from $v_{1} = V_{\\max} S_{1}/(K_M+S_{1})$,\n$$\nV_{\\max} \\;=\\; v_{1}\\,\\frac{K_M+S_{1}}{S_{1}} \\;=\\; v_{1}\\,\\frac{50.0+25.0}{25.0} \\;=\\; 3\\,v_{1}.\n$$\nUsing the tabulated value $v_{1}=33.3$, this gives $V_{\\max}\\approx 100.0$, consistent with the rounded data.\n\nFor competitive inhibition at fixed $S$, solve the velocity expression for $K_I$. Starting from\n$$\nv \\;=\\; \\frac{V_{\\max} S}{K_M\\!\\left(1+\\frac{I}{K_I}\\right)+S},\n$$\ncross-multiply and rearrange:\n$$\nv\\left[K_M\\!\\left(1+\\frac{I}{K_I}\\right)+S\\right] \\;=\\; V_{\\max} S\n\\;\\;\\Longrightarrow\\;\\;\nv K_M \\frac{I}{K_I} \\;=\\; V_{\\max} S - v(S+K_M)\n\\;\\;\\Longrightarrow\\;\\;\nK_I \\;=\\; \\frac{I\\, v\\, K_M}{V_{\\max} S - v(S+K_M)}.\n$$\nInsert $K_M=50.0$ and $V_{\\max}=100.0$ along with any $(S,I,v)$ triplet from the tables. For example, with $S=100.0$, $I=20.0$, $v=50.0$,\n$$\nK_I \\;=\\; \\frac{20.0 \\cdot 50.0 \\cdot 50.0}{100.0 \\cdot 100.0 - 50.0(100.0+50.0)}\n\\;=\\;\n\\frac{50000}{10000 - 7500}\n\\;=\\;\n\\frac{50000}{2500}\n\\;=\\;\n20.0.\n$$\nUsing other data pairs (e.g., $S=25.0$, $I=10.0$, $v=25.0$) yields the same value, confirming internal consistency. Therefore, the inhibitor constant is $K_I=20.0$ in micromolar units, as required.", "answer": "$$\\boxed{20.0}$$", "id": "2071808"}]}